Tickertape - Financial freedom begins here

The company reported a turnover of Rs 1,653 crore in FY26, registering a 13% growth compared with Rs 1,462 crore in FY25. During FY26, the company expanded its retail footprint by opening 13 new stores, adding 78,618 sq. ft. of retail space, including 4 stores under the Kanchipuram Varamahalakshmi Silks format, 8 under the Valli Silks format, and 1 under the Kalamandir format. Consequently, the total store network stood at 81 outlets, with an aggregate retail area of approximately 7.94 lakh sq. ft. Sai Silks (Kalamandir) is predominantly engaged in the business of buying and selling textiles and textile articles as a retailer. It retails sarees, women's wear, men's wear, and kids' wear. The company's standalone net profit tumbled 17.12% to Rs 38.14 crore on an 8.32% drop in revenue from operations to Rs 411.25 crore in Q3 FY26 over Q3 FY25. Shares of Sai Silks (Kalamandir) fell 3.89% to Rs 97.45 on the BSE.

Healtheon AI is a company at the forefront of the agentic AI revolution in healthcare revenue cycle management (RCM) and a leader in building collaborative healthcare specific agentic AI teammates that automate complex tasks and improve efficiency. Unlike traditional automation tools, Healtheon AI's architecture deploys specialized, role-based AI agents working together in a decentralized, fault-tolerant system, capable of handling the complexity and high-stakes nature of healthcare finance. From eligibility verification and prior authorization to medical coding, claims processing, and denial remediation, Healtheon AI's agents integrate seamlessly with human teams to navigate clinical, financial, and regulatory workflows with precision and resilience. The system is built to deploy at scale for real-time processing, with performance contracts anchored in quantifiable outcomes and guaranteed reduction in RCM labor costs and denial leakage. Rajan Sethuraman, CEO, LatentView Analytics, said: 'This investment is a strategic step forward in line with our AI vision of prioritizing advanced technology and proven expertise to deliver maximum value to our clients. With this investment, we are not only investing in healthcare; we are investing in an Agentic AI solution that solves a healthcare problem. LatentView will now be a preferred partner for the deployment of Healtheon AI with its customers.' Latent View Analytics (LatentView) is a global data analytics company. The company provides a 360-degree view of the digital consumer, enabling companies to predict new revenue streams, anticipate product trends and popularity, improve customer retention rates, and optimize investment decisions. The company's consolidated net profit jumped 19.69% to Rs 50.14 crore on 22.02% increase in revenue from operations to Rs 278 crore in Q3 December 2025 over Q3 December 2024.

Divis Laboratories Ltd dropped for a fifth straight session today. The stock is quoting at Rs 5824.5, down 1.39% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 1.28% on the day, quoting at 22388.45. The Sensex is at 72170.86, down 1.32%.Divis Laboratories Ltd has eased around 7.78% in last one month.Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has eased around 4.37% in last one month and is currently quoting at 22011.6, down 1.5% on the day. The volume in the stock stood at 3.7 lakh shares today, compared to the daily average of 2.86 lakh shares in last one month. The benchmark April futures contract for the stock is quoting at Rs 5847.5, down 1.5% on the day. Divis Laboratories Ltd jumped 1.07% in last one year as compared to a 3.71% slide in NIFTY and a 1.21% spurt in the Nifty Pharma index.The PE of the stock is 60.95 based on TTM earnings ending December 25.